Article Details
Retrieved on: 2025-03-14 14:52:37
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses biopharma legislation at the Connecticut state Capitol, focusing on drug pricing and policy issues, such as price controls and the 340B Drug Pricing Program. Initiatives aim to balance affordability with biopharma industry needs. Paul Pescatello emphasizes health cost reduction beyond medication prices, aligning these discussions with the key concept and tags related to drug pricing, policy, and management in the U.S. and Canada.
Article found on: www.cbia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here